TTNP TITAN PHARMACEUTICALS INC Management Changes 8-K Filing 2024 - Management Change Titan Pharmaceuticals appointed Brynner Chiam as acting principal executive officer and acting principal financial officer while searching for a full-time CEO; he will not receive additional compensation for these roles.Get access to all SEC 8-K filings of the TITAN PHARMACEUTICALS INC